mTOR and tau phosphorylated proteins in the hippocampal tissue of rats with type 2 diabetes and Alzheimer's disease

Author： Ma Yun-Qing Wu Dong-Ke Liu Jian-Kun

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.7, Iss.2, 2013-02, pp. : 623-627

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphorylated mTOR Expression is Associated with Poor Prognosis for Patients with Esophageal Squamous Cell Carcinoma

By Hirashima Kotaro

Annals of Surgical Oncology, Vol. 17, Iss. 9, 2010-09 ,pp. : 2486-2493

Springer Publishing Company

Access to resources Recommend Favorite

Updates of mTOR Inhibitors

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 7, 2010-09 ,pp. : 571-581

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of β-site APP-cleaving enzyme 1 in the hippocampal tissue of an insulin-resistant rat model of Alzheimer's disease

Experimental and Therapeutic Medicine, Vol. 9, Iss. 6, 2015-01 ,pp. : 2389-2393

Spandidos Publications

Access to resources Recommend Favorite

Les inhibiteurs de mTOR

By Cortot A. Soria J.-C.

Oncologie, Vol. 8, Iss. 9, 2006-11 ,pp. : 821-827

Springer Publishing Company

Access to resources Recommend Favorite

Role of mTOR in Hematological Malignancies

Current Cancer Therapy Reviews, Vol. 4, Iss. 3, 2008-08 ,pp. : 211-218

Bentham Science Publishers

Access to resources Recommend Favorite